SUBSCRIBE
SUBSCRIBE
News   Policy

Reckitt Benckiser Plc Faces $145.6 Million Lawsuit Over Gaviscon

April 19, 2011 | 
1 min read
(Reuters) - Britain's health authorities are suing consumer goods group Reckitt Benckiser (RB.L) for 89 million pounds ($145.6 million)over the supply of its heartburn medicine Gaviscon, the company said on Sunday.
Legal Europe
MORE ON THIS TOPIC
3d illustration of a black dragon flying on an extraterrestrial world with mountains beneath.
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Bureaucracy and administration management success with a group of tangled red tape and people running away on a pencil drawing line as a bureaucratic solution symbol with 3D illustration elements.
FDA
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews
June 17, 2025
 · 
2 min read
 · 
Annalee Armstrong
National Institutes of Health (NIH) building
Government
Court Orders Restoration of Canceled NIH Grants, Calls Cuts ‘Appalling’
June 17, 2025
 · 
2 min read
 · 
Tristan Manalac